Metraipolis › archive › dc_411ef3252d6c

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38167735
DOI
10.1038/s41541-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-06T19:08:18.745Z
SHA-256 of the archived text
f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a
Stable URL of this page
https://metraipolis.com/documento/dc_411ef3252d6c

How to cite

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735 — Europe PMC (en), https://europepmc.org/article/MED/38167735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_411ef3252d6c (Metraipolis archive dc_411ef3252d6c, sha256 f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a)
BibTeX
@misc{dc411ef3252d6c,
  title = {Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38167735},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_411ef3252d6c; sha256 f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38167735. Agents can read the archived copy with the MCP tool read_document.